OrbusNeich, Boston Scientific Settle Stent Patent Litigation
September 20, 2013 – OrbusNeich Medical Inc. and Boston Scientific Corp. have settled all stent-related litigation between the companies. The agreement resolves cases brought by the parties in Germany, the Netherlands, Ireland, the United Kingdom and the United States. The agreement, which includes a one-time payment from Boston Scientific to OrbusNeich, settles all stent-related disputes and does not include future financial obligations.
For more information: www.OrbusNeich.com, www.bostonscientific.com
More like this
- OrbusNeich Files Patent Infringement Actions Against Boston Scientific in Germany and the Netherlands
- OrbusNeich Issues Statement on Boston Scientific's Retaliatory Litigation Efforts
- Cell-Coated Stent as Effective as DES, but Fewer Drugs Are Needed
- OrbusNeich Files Lawsuit Over Stent Clinical Trial Results